Sg3 Management, LLC Cassava Sciences Inc Put Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $2 Million - $4.46 Million	-115,900 Reduced 78.9%	31,000 $872,000
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $2.83 Million - $4.61 Million	86,900 Added 144.83%	146,900 $5.46 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $2.51 Million - $8.12 Million	60,000 New	60,000 $3.73 Million

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.06B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.